Dr Shalini Saith, MD | |
13685 Doctors Way Ste 330, Fort Myers, FL 33912-4347 | |
(239) 343-1400 | |
(239) 343-1430 |
Full Name | Dr Shalini Saith |
---|---|
Gender | Female |
Speciality | Nephrology |
Experience | 18 Years |
Location | 13685 Doctors Way Ste 330, Fort Myers, Florida |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154551521 | NPI | - | NPPES |
015680300 | Medicaid | FL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | 072910 (Georgia) | Secondary |
207RN0300X | Internal Medicine - Nephrology | ME124880 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Cleveland Clinic Hospital | Weston, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Cleveland Clinic Florida A Nonprofit Corporation | 7911807128 | 618 |
News Archive
The Canadian Cardiovascular Society is the first in Canada to issue guidelines aimed at helping primary care and emergency physicians, as well as specialists, recognize and manage heart failure in children. The guidelines were released today at the Canadian Cardiovascular Congress.
A paper published today in Science Translational Medicine describes a simple, minimally invasive new tool for viewing differences in the nasal airways of cystic fibrosis patients in vivo at a cellular level.
Luminescent markers are an indispensable tool for researchers working with DNA. But the markers are troublesome. Some tend to destroy the function and structure of DNA when inserted. Others emit so little light, that they can barely be detected in the hereditary material. So researchers have been asking for alternative markers.
The administration announces that almost 2.8 million people have saved an average $677, because the law is closing the prescription drug doughnut hole.
Orexo AB announces today that its partner Kyowa Hakko Kirin Co., Ltd. has entered a joint distribution agreement for the cancer pain drug KW-2246 (Orexo's sublingual fentanyl product) with the pharmaceutical company Hisamitsu Pharmaceutical Co., Inc.
› Verified 9 days ago
Entity Name | Cleveland Clinic Florida A Nonprofit Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215989298 PECOS PAC ID: 7911807128 Enrollment ID: O20040113000394 |
News Archive
The Canadian Cardiovascular Society is the first in Canada to issue guidelines aimed at helping primary care and emergency physicians, as well as specialists, recognize and manage heart failure in children. The guidelines were released today at the Canadian Cardiovascular Congress.
A paper published today in Science Translational Medicine describes a simple, minimally invasive new tool for viewing differences in the nasal airways of cystic fibrosis patients in vivo at a cellular level.
Luminescent markers are an indispensable tool for researchers working with DNA. But the markers are troublesome. Some tend to destroy the function and structure of DNA when inserted. Others emit so little light, that they can barely be detected in the hereditary material. So researchers have been asking for alternative markers.
The administration announces that almost 2.8 million people have saved an average $677, because the law is closing the prescription drug doughnut hole.
Orexo AB announces today that its partner Kyowa Hakko Kirin Co., Ltd. has entered a joint distribution agreement for the cancer pain drug KW-2246 (Orexo's sublingual fentanyl product) with the pharmaceutical company Hisamitsu Pharmaceutical Co., Inc.
› Verified 9 days ago
Entity Name | Gulati & Associates Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1073524161 PECOS PAC ID: 4587852504 Enrollment ID: O20101217000213 |
News Archive
The Canadian Cardiovascular Society is the first in Canada to issue guidelines aimed at helping primary care and emergency physicians, as well as specialists, recognize and manage heart failure in children. The guidelines were released today at the Canadian Cardiovascular Congress.
A paper published today in Science Translational Medicine describes a simple, minimally invasive new tool for viewing differences in the nasal airways of cystic fibrosis patients in vivo at a cellular level.
Luminescent markers are an indispensable tool for researchers working with DNA. But the markers are troublesome. Some tend to destroy the function and structure of DNA when inserted. Others emit so little light, that they can barely be detected in the hereditary material. So researchers have been asking for alternative markers.
The administration announces that almost 2.8 million people have saved an average $677, because the law is closing the prescription drug doughnut hole.
Orexo AB announces today that its partner Kyowa Hakko Kirin Co., Ltd. has entered a joint distribution agreement for the cancer pain drug KW-2246 (Orexo's sublingual fentanyl product) with the pharmaceutical company Hisamitsu Pharmaceutical Co., Inc.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Shalini Saith, MD Po Box 2147, Fort Myers, FL 33902-2147 Ph: (239) 424-1449 | Dr Shalini Saith, MD 13685 Doctors Way Ste 330, Fort Myers, FL 33912-4347 Ph: (239) 343-1400 |
News Archive
The Canadian Cardiovascular Society is the first in Canada to issue guidelines aimed at helping primary care and emergency physicians, as well as specialists, recognize and manage heart failure in children. The guidelines were released today at the Canadian Cardiovascular Congress.
A paper published today in Science Translational Medicine describes a simple, minimally invasive new tool for viewing differences in the nasal airways of cystic fibrosis patients in vivo at a cellular level.
Luminescent markers are an indispensable tool for researchers working with DNA. But the markers are troublesome. Some tend to destroy the function and structure of DNA when inserted. Others emit so little light, that they can barely be detected in the hereditary material. So researchers have been asking for alternative markers.
The administration announces that almost 2.8 million people have saved an average $677, because the law is closing the prescription drug doughnut hole.
Orexo AB announces today that its partner Kyowa Hakko Kirin Co., Ltd. has entered a joint distribution agreement for the cancer pain drug KW-2246 (Orexo's sublingual fentanyl product) with the pharmaceutical company Hisamitsu Pharmaceutical Co., Inc.
› Verified 9 days ago
Anthony A Mcfarlane, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 8960 Colonial Center Dr Ste 302, Fort Myers, FL 33905 Phone: 239-343-9700 Fax: 239-343-9699 | |
Scott Francis Allen, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1550 Barkley Cir, Fort Myers, FL 33907 Phone: 239-938-2000 | |
Dr. Jyothsna Priyadarshini Bandaru, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3725 Piazza Dr Apt 202, Fort Myers, FL 33916 Phone: 000-000-0000 | |
Dr. Daniel Morales, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 9981 S Healthpark Dr, Fort Myers, FL 33908 Phone: 239-343-2052 Fax: 239-343-5348 | |
Richard A Chazal, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 9800 S Health Park Dr, Suite 320, Fort Myers, FL 33908 Phone: 239-343-6350 Fax: 239-343-6358 | |
Dr. James M Toomey, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 13340 Metro Pkwy Ste 310, Fort Myers, FL 33966 Phone: 239-343-1448 Fax: 239-343-1449 | |
Charles M Callahan, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2780 Cleveland Ave Ste 809, Fort Myers, FL 33901 Phone: 239-343-9680 Fax: 239-343-4178 |